| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig.1.F
Mukherjee S et al. (2020)
|
Xtr Wt + sox17a MO + sox17b.1/b.2 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig.5.Col.2
Mukherjee S et al. (2020)
|
Xtr Wt + sox17a MO + sox17b.1/b.2 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig.1.S1.D
Mukherjee S et al. (2020)
|
Xtr Wt + sox17a MO + sox17b.1/b.2 MO
NF10.5 (in situ hybridization)
|
|
|
|
|
Fig.1.S1.C
Mukherjee S et al. (2020)
|
Xtr Wt + sox17a MO + sox17b.1/b.2 MO
NF35/36 (in situ hybridization)
|
|
|
|
Figure 2.F
Sinner D et al. (2007)
|
Xla Wt + sox17a MO + sox17b.1 MO
NF11 (RT-PCR)
|
|
|
|
|
Figure 2.G
Sinner D et al. (2007)
|
Xla Wt + sox17a MO + sox17b.1 MO
NF11 (RT-PCR)
|
|
|
|
fig.4.a
Sinner D et al. (2006)
|
Xla Wt + sox17a MO + sox17b.1 MO
NF11 (microarray)
|
|
|
|
fig.5.a
Sinner D et al. (2006)
|
Xla Wt + sox17a MO + sox17b.1 MO
NF11 (real time PCR)
|
|
|
|
|
fig.4.b
Sinner D et al. (2006)
|
Xla Wt + sox17a MO + sox17b.1 MO
NF11 (RT-PCR)
|
|
|
|
fig.S1
Sinner D et al. (2004)
|
Xla Wt + sox17a
NF11-12 (RT-PCR)
|
|
|